Literature DB >> 15533560

Analysis of a staging assessment system for prediction of surgical interval in recurrent respiratory papillomatosis.

Craig S Derkay1, Ryan P Hester, Bonnie Burke, Jeff Carron, Louise Lawson.   

Abstract

INTRODUCTION: A staging system for assessment of recurrent respiratory papillomatosis (RRP) has been in use over the last 3 years for 17 patients at our children's hospital.
OBJECTIVE: To evaluate a staging system for assessment of RRP on the basis of the predictive value on the surgical interval of: anatomic staging system score, urgency of intervention, voice quality, and stridor. To assess effect on surgical interval of the age of patient at time of surgery and use of adjuvant therapy. To develop a model based on the staging criteria to predict need for adjuvant therapy.
DESIGN: Validation cohort.
SETTING: Academic children's hospital.
RESULTS: Estimated time to surgery decreased by "x days": "independent variable" "(95% CI)" as follows. Four days: each 1 point in total anatomical score (0.2, 8); 120 days: total anatomical score >20 (37,203); 143 days: urgent versus scheduled surgery (42, 243); 100 days: aphonic versus normal voice (-211, 343); 31 days: abnormal versus normal voice (-281, 343); 125 days: stridor at rest versus no stridor (-31, 281); 109 days: stridor with activity versus no stridor (19, 198); 26 days: each 1 year decrease in age (22, 30). Adjuvant therapy delays next surgery by 32 days (-4, 69) and average scores decreased while on adjuvant therapy.
CONCLUSIONS: Elements of our proposed staging system are effective in prediction of surgical interval with statistical significance achieved for total anatomical scores, urgency of intervention and stridor with activity versus no stridor. This study is pilot in nature and provides a framework upon which future studies can be based. The analysis of a larger, more severity diverse population could yield results which lead to a model capable of effectively predicting future surgical interval based on a weighted prediction score calculated from age, comorbidities, anatomic staging score, and clinical staging score.

Entities:  

Mesh:

Year:  2004        PMID: 15533560     DOI: 10.1016/j.ijporl.2004.06.007

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  7 in total

1.  The impact of cidofovir treatment on viral loads in adult recurrent respiratory papillomatosis.

Authors:  S Mikolajczak; G Quante; S Weissenborn; A Wafaisade; U Wieland; J C Lüers; J P Klussmann; D Beutner
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-06       Impact factor: 2.503

Review 2.  Recurrent respiratory papillomatosis.

Authors:  Naren N Venkatesan; Harold S Pine; Michael P Underbrink
Journal:  Otolaryngol Clin North Am       Date:  2012-06       Impact factor: 3.346

Review 3.  Emerging and re-emerging infectious disease in otorhinolaryngology.

Authors:  F Scasso; G Ferrari; G C DE Vincentiis; A Arosio; S Bottero; M Carretti; A Ciardo; S Cocuzza; A Colombo; B Conti; A Cordone; M DE Ciccio; E Delehaye; L Della Vecchia; I DE Macina; C Dentone; P DI Mauro; R Dorati; R Fazio; A Ferrari; G Ferrea; S Giannantonio; I Genta; M Giuliani; D Lucidi; L Maiolino; G Marini; P Marsella; D Meucci; T Modena; B Montemurri; A Odone; S Palma; M L Panatta; M Piemonte; P Pisani; S Pisani; L Prioglio; A Scorpecci; L Scotto DI Santillo; A Serra; C Signorelli; E Sitzia; M L Tropiano; M Trozzi; F M Tucci; L Vezzosi; B Viaggi
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-04       Impact factor: 2.124

Review 4.  Recurrent respiratory papillomatosis: current and future perspectives.

Authors:  Marco Carifi; Domenico Napolitano; Morando Morandi; Danilo Dall'Olio
Journal:  Ther Clin Risk Manag       Date:  2015-05-05       Impact factor: 2.423

5.  Lymphocyte profile and cytokine mRNA expression in peripheral blood mononuclear cells of patients with recurrent respiratory papillomatosis suggest dysregulated cytokine mRNA response and impaired cytotoxic capacity.

Authors:  Anna Holm; Olga Nagaeva; Ivan Nagaev; Christos Loizou; Göran Laurell; Lucia Mincheva-Nilsson; Karin Nylander; Katarina Olofsson
Journal:  Immun Inflamm Dis       Date:  2017-08-14

6.  Coordinated Expression of HPV-6 Genes with Predominant E4 and E5 Expression in Laryngeal Papilloma.

Authors:  Taro Ikegami; Hitoshi Hirakawa; Narutoshi Tsukahara; Akikazu Murakami; Norimoto Kise; Asanori Kiyuna; Takayoshi Kosugi; Shinya Agena; Hidetoshi Kinjyo; Narumi Hasegawa; Masatomo Touyama; Shunsuke Kondo; Hiroyuki Maeda; Mikio Suzuki; Akira Ganaha
Journal:  Microorganisms       Date:  2021-03-03

7.  Development of Antibodies against HPV-6 and HPV-11 for the Study of Laryngeal Papilloma.

Authors:  Taro Ikegami; Norimoto Kise; Hidetoshi Kinjyo; Shunsuke Kondo; Mikio Suzuki; Narutoshi Tsukahara; Akikazu Murakami; Asanori Kiyuna; Shinya Agena; Katsunori Tanaka; Narumi Hasegawa; Junko Kawakami; Akira Ganaha; Hiroyuki Maeda; Hitoshi Hirakawa
Journal:  Viruses       Date:  2021-10-07       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.